[Federal Register: May 15, 2003 (Volume 68, Number 94)]
[Notices]
[Page 26315-26316]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15my03-65]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of
the National Cancer Advisory Board.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in sections 552b(c)(4), and 552b(6), as
amended. The grant applications and the discussions could disclose
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board.
Dates: June 10, 2003.
Open: June 10, 2003, 8:30 a.m. to 12 p.m.
Agenda: Program reports and presentations; Business of the
Board.
Place: National Cancer Institute, 9000 Rockville Pike, Building
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
Contact: Dr. Paulette S. Gray, Acting Executive Secretary,
National Cancer Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, Room 8141, Bethesda, MD 20892, (301)
496-4218.
Name of Committee: National Cancer Advisory Board, Ad Hoc
Subcommittee on Confidentiality of Patient Data.
Open: June 10, 2003, 12 p.m. to 1 p.m.
Agenda: To discuss activities related to the Ad Hoc subcommittee
on Confidentiality of Patient Data.
Place: National Cancer Institute, 9000 Rockville Pike, Building
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
Contact Person: Ms. Mary McCabe, Executive Secretary, Ad Hoc
Subcommittee on Confidentiality of Patient Data, National Cancer
Institute, National Institutes of Health, 9000 Rockville Pike,
Building 31, Room 3A44, Bethesda, MD 20892, (301) 496-6404.
Name of Committee: National Cancer Advisory Board, Subcommittee
on Clinical Investigations.
Open: June 10, 2003, 12 p.m. to 1 p.m.
Agenda: To discuss activities related to the Subcommittee on
Clinical Investigations.
Place: National Cancer Institute, 9000 Rockville Pike, Building
31, C Wing, 6th Floor, Conference Room 8, Bethesda, MD 20892.
Contact Person: Dr. Ellen Feigal, Executive Secretary,
Subcommittee on Clinical Investigations, National Cancer Institute,
National Institutes of Health, 9000 Rockville Pike, Building 31,
Room 3A44, Bethesda, MD 20892, (301) 496-4291.
Name of Committee: National Cancer Advisory Board.
Open: June 10, 2003, 1 p.m. to 2 p.m.
Agenda: Program reports and presentations; Business of the
Board.
Place: National Cancer Institute, 9000 Rockville Pike, Building
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
Contact: Dr. Paulette S. Gray, Acting Executive Secretary,
National Cancer Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, Room 8141, Bethesda, MD 20892, (301)
496-4218.
Name of Committee: National Cancer Advisory Board, Subcommittee
on Planning and Budget.
Open: June 10, 2003, 2 p.m. to 2:45 p.m.
Agenda: Bypass Budget Update.
Place: National Cancer Institute, 9000 Rockville Pike, Building
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
Contact Person: Ms. Cherie Nichols, Executive Secretary,
Subcommittee on Planning and Budget, National Cancer Institute,
National Institutes of Health, 9000 Rockville Pike, Building 31,
Room 11A03, Bethesda, MD 20892, (301) 496-5515.
Name of Committee: National Cancer Advisory Board.
Open: June 10, 2003, 2:45 p.m. to 4:25 p.m.
Agenda: Program reports and presentations; Business of the
Board.
Place: National Cancer Institute, 9000 Rockville Pike, Building
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
Contact Person: Dr. Paulette S. Gray, Acting Executive
Secretary, National Cancer Institute, National Institutes of Health,
6116 Executive Boulevard, 8th Floor, room 8141, Bethesda, MD 20892,
(301) 496-4218.
Name of Committee: National Cancer Advisory Board,
Closed: June 10, 2003, 4:25 p.m. to Adjournment.
Agenda: Review of grant applications.
Contact Person: Dr. Paulette S. Gray, Acting Executive
Secretary, National Cancer Institute, National Institutes of Health,
6116 Executive Boulevard, 8th Floor, Room 8141, Bethesda, MD 20892,
(301) 496-4218.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance into the building by non-government employees.
Persons without a government I.D. will need to show a photo I.D. and
sign-in at the security desk upon entering the building.
Information is also available on the Institute's/Center's home
page: http://deainfo.nci.nih.gov/advisory/ncab.htm, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396. Cancer Biology Research; 93.397, Cancer
Centers Support, 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
[[Page 26316]]
Dated: May 8, 2003.
Anna P. Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-12074 Filed 5-14-03; 8:45 am]
BILLING CODE 4140-01-M